Pinnacle Bancorp Inc. Acquires 50 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Pinnacle Bancorp Inc. grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 50.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 150 shares of the company’s stock after buying an additional 50 shares during the quarter. Pinnacle Bancorp Inc.’s holdings in HCA Healthcare were worth $45,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in HCA. FMR LLC lifted its holdings in shares of HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Darsana Capital Partners LP boosted its position in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares during the last quarter. Meritage Group LP acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $150,548,000. Holocene Advisors LP boosted its holdings in HCA Healthcare by 210.6% during the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after purchasing an additional 208,015 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in HCA Healthcare by 29.7% during the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after buying an additional 193,075 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently issued reports on HCA. Truist Financial dropped their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Barclays cut their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Price Performance

NYSE:HCA opened at $309.26 on Friday. The firm’s 50-day simple moving average is $318.49 and its 200 day simple moving average is $353.11. HCA Healthcare, Inc. has a 52 week low of $276.50 and a 52 week high of $417.14. The firm has a market cap of $78.34 billion, a price-to-earnings ratio of 13.89, a P/E/G ratio of 1.03 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.